Publications by authors named "Gary J Moet"

Claim this Profile
I
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Michael A Pfaller, Frederick Duncanson, Shawn A Messer, Gary J Moet, Ronald N Jones

Antimicrob Agents Chemother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Michael A Pfaller, Katsura Hata, Ronald N Jones, Shawn A Messer, Gary J Moet

Diagn Microbiol Infect Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Michael A Pfaller, Shawn A Messer, Gary J Moet, Ronald N Jones, Mariana Castanheira

Int J Antimicrob Agents· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Helio S Sader, Gary J Moet, David J Farrell, Ronald N Jones

Diagn Microbiol Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
Michael A Pfaller, Gary J Moet, Shawn A Messer, Ronald N Jones, Mariana Castanheira

Antimicrob Agents Chemother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).
Michael A Pfaller, Gary J Moet, Shawn A Messer, Ronald N Jones, Mariana Castanheira

J Clin Microbiol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Michael A Pfaller, Mariana Castanheira, Shawn A Messer, Gary J Moet, Ronald N Jones

Diagn Microbiol Infect Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
Michael A Pfaller, Mariana Castanheira, Shawn A Messer, Gary J Moet, Ronald N Jones

Diagn Microbiol Infect Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009).
Ronald N Jones, Helio S Sader, Gary J Moet, David J Farrell

Diagn Microbiol Infect Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).
Shawn A Messer, Ronald N Jones, Gary J Moet, Jeffrey T Kirby, Mariana Castanheira

J Clin Microbiol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results.
Shannon D Putnam, Helio S Sader, Gary J Moet, Rodrigo E Mendes, Ronald N Jones

Diagn Microbiol Infect Dis· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Rodrigo E Mendes, Gary J Moet, Mike J Janechek, Ronald N Jones

Antimicrob Agents Chemother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
Shannon D Putnam, Mariana Castanheira, Gary J Moet, David J Farrell, Ronald N Jones

Diagn Microbiol Infect Dis· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Helio S Sader, Holly K Becker, Gary J Moet, Ronald N Jones

Diagn Microbiol Infect Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
Gary J Moet, Amy A Watters, Helio S Sader, Ronald N Jones

Diagn Microbiol Infect Dis· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).
Shawn A Messer, Gary J Moet, Jeffrey T Kirby, Ronald N Jones

J Clin Microbiol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
Ronald N Jones, Gary J Moet, Helio S Sader, Rodrigo E Mendes, Mariana Castanheira

J Antimicrob Chemother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation.
Ronald N Jones, Thomas R Fritsche, Gary J Moet

Diagn Microbiol Infect Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
Lalitagauri M Deshpande, Thomas R Fritsche, Gary J Moet, Douglas J Biedenbach, Ronald N Jones

Diagn Microbiol Infect Dis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
Gary J Moet, Michael J Dowzicky, Ronald N Jones

Diagn Microbiol Infect Dis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Gary J Moet, Ronald N Jones, Douglas J Biedenbach, Matthew G Stilwell, Thomas R Fritsche

Diagn Microbiol Infect Dis· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
Douglas J Biedenbach, Gary J Moet, Ronald N Jones

Diagn Microbiol Infect Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
Ronald N Jones, Gary J Moet, Helio S Sader, Thomas R Fritsche

J Antimicrob Chemother· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis